Home › Core › ISCC-IDs › 28C6eeV4wgz3R

View ISCC-ID

Core Data

28C6eeV4wgz3R
ISCC-ID - digital asset identifier
CCXTuaYqAmqe5-CT5BDvwuatz1Z-CDV7g7Fxj95JT-CR1rHemeXgE1W
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

spiro heterocyclic compounds i synthesis of spiroimidazolidine43indoline225triones

Ledger Reference

coblo
Source Ledger/Blockchain
12407627
N-th ISCC Decleration on source ledger
789b9486d66fd11539089d4debbedf3f161c315d5ea4e5eab835ff2f445b102a
Hash of block that includes the ISCC-DECLARATION
848552235b2093b0c39c5041f7200394681b58e637555872e0fc1e60b5ba0c94
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Spiro heterocyclic compounds. I. Synthesis of spiro-(imidazolidine-4,3'-indoline)-2,2',5-triones.", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "HIROTAKA OTOMASU", "@type": "Person"}, {"name": "KYUJI NATORI", "@type": "Person"}, {"name": "HIROSHI TAKAHASHI", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://www.jstage.jst.go.jp/article/cpb1958/23/7/23_7_1431/_pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "Pharmaceutical Society of Japan", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1248/cpb.23.1431", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCXTuaYqAmqe5-CT5BDvwuatz1Z-CDV7g7Fxj95JT-CR1rHemeXgE1W", "propertyID": "ISCC"}], "datePublished": "1975-01-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close